Wacker Chemie AG (WCHG.DE)
23 Mar 2018
* SAYS OBTAINS FDA APPROVAL TO MANUFACTURE THE DRUG SUBSTANCE IN RETAVASE, A THROMBOLYSIS MEDICATION BY CHIESI Source text: https://www.wacker.com/cms/en/home/index.jsp Further company coverage:
FRANKFURT, Oct 26 Wacker Chemie will see a significant hit to volumes of polysilicon in the fourth quarter as a result of an outage at its plant in Charleston, Tennessee, following an explosion at the site last month, its chief financial officer said.
* Shares indicated 2.6 pct higher (Recasts, adds context on results, shares)
FRANKFURT, Oct 26 German specialty chemicals maker Wacker Chemie on Thursday raised its outlook for core earnings for the second time in three months, pointing to "markedly higher" demand as well as income from its stake in Siltronic.